OrbiMed Israel GP Ltd.'s Form 4 filing
Tessera Defense & Homeland Security Inc. (HLSQ) · filed Jul 30, 2021
- Accession no.
- 0000947871-21-000844
- Filed
- Jul 30, 2021, 6:20 PM ET
- Trade date
- Jul 28, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Israel GP Ltd.CIK 0001569590 | 10% Owner |
| OrbiMed Israel BioFund GP Limited PartnershipCIK 0001569821 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 | Common Stock, $0.0001 par value | PPurchaseAcquired | +500,000 | –F1 | – | 2,813,489 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 | Common Stock | PPurchaseAcquired | +375,000 | –F1 | – | 375,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
In the Issuer's underwritten public offering, OrbiMed Israel Partners Limited Partnership ("OIP") purchased units that included 500,000 shares of the Issuer's common stock and 375,000 warrants, each exercisable for 1 share of the Issuer's common stock. The purchase price of each unit was $4.00.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.